Xanthelasma

Xanthelasma (Eyelid Cholesterol Deposits)

Xanthelasma is a benign eyelid condition characterized by yellowish cholesterol deposits beneath the skin, most commonly occurring near the inner corners of the eyelids.

Category Benign Eyelid Lesion
Location Medial Upper & Lower Eyelids
Tissue Involved Skin & Subcutaneous Tissue
Main Concern Cosmetic Appearance & Lipid Association

What Is Xanthelasma?

Xanthelasma is a common benign eyelid lesion caused by accumulation of cholesterol-containing deposits within the skin of the eyelids.


It appears as soft, yellow or yellow-white plaques, usually located near the inner corners of the eyelids. The lesions are often symmetrical and may slowly increase in size over time.


Although xanthelasma itself is not cancerous and does not threaten vision, its presence may be associated with underlying lipid abnormalities such as elevated cholesterol or triglyceride levels.


Evaluation may be recommended to assess cardiovascular risk factors and identify possible metabolic conditions.

Eyelid Anatomy

The eyelids contain specialized structures responsible for protection, lubrication, and maintaining a healthy ocular surface.


Eyelid Skin

Thin skin that may develop deposits or growths.

Orbicularis Oculi Muscle

Muscle responsible for eyelid closure and blinking.

Tarsal Plate

Provides structural support to the eyelid.

Eyelid Margin

Contains eyelashes and specialized glands.

Important Eyelid Structures

Understanding eyelid structures helps explain where xanthelasma develops and how it differs from other eyelid lesions.


Meibomian Glands

Oil-producing glands that contribute to tear film stability.

Conjunctiva

Protective mucous membrane lining the inner eyelid.

Eyelid Blood Supply

Provides nutrients and immune support to eyelid tissues.

Subcutaneous Tissue

The layer where cholesterol deposits accumulate.

What Causes Xanthelasma?

Xanthelasma develops when cholesterol and lipid-containing cells accumulate in the skin around the eyelids.


Cholesterol Deposition

Lipids collect within skin macrophages, forming visible plaques.

Abnormal Lipid Metabolism

Changes in cholesterol processing may contribute.

Macrophage Accumulation

Immune cells store excess cholesterol within tissues.

Genetic Predisposition

Some individuals have increased susceptibility.

Risk Factors

Hyperlipidemia

Elevated cholesterol or triglyceride levels may be associated.

Family History

Genetic lipid disorders may increase risk.

Diabetes Mellitus

Metabolic changes may contribute to lipid imbalance.

Thyroid Disease

Thyroid dysfunction may affect cholesterol metabolism.

Clinical Appearance of Xanthelasma

Xanthelasma has a characteristic appearance that often allows diagnosis through clinical examination.


Yellow Plaques

Flat or slightly raised yellow deposits beneath the skin.

Medial Eyelid Location

Frequently appears near the inner corners of the eyelids.

Symmetric Distribution

Often affects both eyes.

Slow Enlargement

Lesions may gradually increase in size over years.

Types of Xanthomas

Xanthelasma is one type of xanthoma, a group of disorders involving lipid deposition in tissues.


Xanthelasma

Cholesterol deposits occurring around the eyelids.

Tendon Xanthomas

Lipid deposits involving tendons.

Tuberous Xanthomas

Nodular lipid deposits over pressure points.

Eruptive Xanthomas

Multiple small lipid lesions associated with high triglycerides.

Symptoms & Clinical Signs

Xanthelasma is usually a painless condition and is often discovered because of its appearance rather than symptoms.


Common Symptoms

  • Yellowish eyelid patches
  • Cosmetic concern
  • Slow enlargement of lesions
  • Mild skin elevation
  • Awareness of eyelid appearance
  • Occasional skin irritation

Clinical Findings

  • Soft yellow plaques
  • Flat or slightly raised lesions
  • Medial eyelid involvement
  • Bilateral distribution
  • Symmetric appearance
  • Well-defined borders

Characteristic Appearance of Xanthelasma

The appearance of xanthelasma is often distinctive and helps differentiate it from other eyelid lesions.


Color

Typically yellow, cream, or yellow-white due to lipid accumulation.

Texture

Usually soft, smooth, and slightly elevated.

Location

Most commonly affects the inner portions of upper eyelids.

Growth Pattern

Usually develops slowly over months or years.

Diagnosis of Xanthelasma

Diagnosis is usually made clinically through examination of the eyelid lesion. Additional testing may be performed to identify associated systemic conditions.


Patient History

Includes duration, progression, family history, and medical conditions.

External Examination

Evaluates lesion appearance, location, and characteristics.

Slit Lamp Examination

Provides magnified assessment of eyelid and ocular structures.

Laboratory Testing

Evaluates cholesterol and metabolic risk factors.

External Eyelid Examination

A detailed eyelid examination helps confirm the diagnosis and exclude other lesions.


Lesion Location

Determines whether lesions involve upper eyelid, lower eyelid, or both.

Size Assessment

Documents lesion dimensions and progression.

Color Evaluation

Yellow coloration supports lipid deposition.

Surface Characteristics

Assesses smoothness, elevation, and borders.

Slit Lamp Examination

A slit lamp examination provides magnified evaluation of eyelid tissue and helps distinguish xanthelasma from other eyelid lesions.


Eyelid Margin Evaluation

Assesses involvement near eyelashes and glands.

Skin Assessment

Evaluates lesion depth and tissue characteristics.

Ocular Surface Evaluation

Ensures there is no associated ocular irritation.

Lipid Evaluation

Because xanthelasma may be associated with abnormal cholesterol levels, systemic evaluation is often considered.


Total Cholesterol

Measures overall cholesterol concentration.

LDL Cholesterol

Evaluates low-density lipoprotein levels.

HDL Cholesterol

Measures protective high-density lipoprotein levels.

Triglycerides

Assesses another important lipid marker.

Systemic Associations

Xanthelasma may occur in individuals with normal lipid levels, but it can also be associated with metabolic disorders.


Hypercholesterolemia

Elevated cholesterol levels may contribute to lipid deposition.

Familial Lipid Disorders

Inherited cholesterol abnormalities may increase risk.

Diabetes Mellitus

Metabolic changes may affect lipid balance.

Thyroid Dysfunction

Thyroid disorders can influence cholesterol metabolism.

Cardiovascular Risk Considerations

Xanthelasma itself is harmless, but its presence may indicate increased cardiovascular risk in some patients.


Lipid Screening

Helps identify abnormal cholesterol levels.

Risk Assessment

Considers overall cardiovascular health.

Lifestyle Evaluation

Addresses diet, exercise, and metabolic health.

Differential Diagnosis

Several eyelid conditions may resemble xanthelasma and should be considered during evaluation.


Sebaceous Carcinoma

A malignant eyelid tumor that may mimic chronic eyelid changes.

Syringoma

Benign sweat gland tumors appearing as small eyelid bumps.

Seborrheic Keratosis

Benign pigmented skin growth.

Nevus

Benign pigmented eyelid lesion.

Milia

Small keratin-filled cysts of the skin.

Eyelid Papilloma

Benign epithelial growth.

When Is Biopsy Considered?

Xanthelasma is usually diagnosed clinically, but biopsy may be considered when the appearance is atypical.


Rapid Growth

Unexpected enlargement requires further evaluation.

Unusual Appearance

Pigmentation or irregular features may require testing.

Diagnostic Uncertainty

Biopsy confirms the diagnosis when needed.

Treatment Options for Xanthelasma

Xanthelasma is a benign condition and treatment is usually performed for cosmetic reasons. Management may also include addressing underlying lipid abnormalities.


Observation

Small stable lesions that do not bother the patient may simply be monitored.

Lipid Management

Treatment of cholesterol abnormalities may reduce future lesion development.

Cosmetic Removal

Procedures may improve appearance when lesions are bothersome.

Medical Management

Although removing cholesterol deposits improves appearance, controlling underlying metabolic risk factors is important.


Diet Modification

A heart-healthy diet may help improve cholesterol levels.

Exercise

Regular physical activity supports healthy lipid metabolism.

Weight Management

Maintaining a healthy weight may improve cardiovascular risk factors.

Lipid-Lowering Medication

Statins or other medications may be recommended when clinically appropriate.

Lifestyle Management

Lifestyle changes may not remove existing xanthelasma but can help reduce future lipid-related problems.


Healthy Dietary Choices

  • Reduce saturated fats
  • Increase fruits and vegetables
  • Choose healthy fats
  • Maintain balanced nutrition

Cardiovascular Prevention

  • Monitor cholesterol levels
  • Control blood sugar
  • Exercise regularly
  • Manage blood pressure

Procedural Treatment Options

Several procedures can remove xanthelasma. The best option depends on lesion size, depth, skin type, and cosmetic goals.


Surgical Excision

The lesion is removed using surgical techniques while preserving eyelid function.

Laser Therapy

Laser energy can remove superficial deposits with controlled tissue treatment.

Chemical Peeling

Chemical agents may dissolve superficial cholesterol deposits.

Cryotherapy

Controlled freezing may destroy abnormal tissue.

Surgical Excision

Surgical removal is commonly considered for larger or deeper lesions.


Procedure

The cholesterol-containing tissue is carefully removed.

Advantages

Provides immediate removal and tissue diagnosis if needed.

Considerations

Larger lesions may require careful reconstruction to maintain eyelid function.

Laser Treatment

Laser therapy may be used for selected superficial xanthelasma lesions.


Carbon Dioxide Laser

Ablates superficial tissue containing cholesterol deposits.

Argon Laser

May be used for selected lesions.

Cosmetic Benefit

Can improve appearance with controlled tissue removal.

Chemical Peel Treatment

Chemical treatment can be used to remove superficial lesions in selected patients.


Trichloroacetic Acid (TCA)

A commonly used chemical agent for superficial xanthelasma.

Controlled Application

Requires careful technique near the delicate eyelid skin.

Multiple Treatments

Some patients may require repeated sessions.

Cryotherapy

Cryotherapy uses controlled freezing to destroy superficial abnormal tissue.


Mechanism

Freezing damages targeted cells.

Advantages

A minimally invasive treatment option.

Considerations

May cause temporary skin changes.

Choosing the Best Treatment

Treatment decisions depend on several patient-specific factors.


Lesion Size

Larger plaques may require surgical approaches.

Lesion Depth

Deeper deposits may be more difficult to remove.

Skin Characteristics

Skin type influences healing and pigment changes.

Cosmetic Goals

Treatment is individualized based on patient expectations.

Preventing Recurrence

Xanthelasma can return after removal, especially when underlying lipid abnormalities remain.


Control Cholesterol

Managing lipid levels may reduce recurrence risk.

Regular Monitoring

Periodic health evaluations support prevention.

Healthy Lifestyle

Long-term lifestyle changes support metabolic health.

Complications of Treatment

Scarring

Some procedures may leave visible scars.

Skin Color Changes

Pigment changes may occur after treatment.

Recurrence

Lesions may return after removal.

Eyelid Contour Changes

Aggressive removal may affect eyelid appearance.

Long-Term Management

Lipid Follow-Up

Monitor cholesterol and metabolic health.

Skin Monitoring

Observe for new or changing lesions.

Healthy Lifestyle

Supports overall cardiovascular health.

Specialist Follow-Up

Additional care may be needed for recurrent lesions.

Complications of Xanthelasma

Xanthelasma is a benign condition and usually does not threaten vision. However, it may have cosmetic, metabolic, or recurrence-related concerns.


Local Complications

  • Cosmetic appearance concerns
  • Progressive enlargement
  • Multiple eyelid lesions
  • Skin texture changes
  • Psychological impact

Systemic Considerations

  • Possible lipid abnormalities
  • Associated cardiovascular risk factors
  • Familial cholesterol disorders
  • Metabolic disease evaluation

Recurrence of Xanthelasma

Even after successful removal, xanthelasma may return because the underlying tendency for cholesterol deposition can persist.


Persistent Lipid Abnormalities

Uncontrolled cholesterol disorders may increase recurrence risk.

Incomplete Removal

Residual deposits may contribute to recurrence.

New Lesion Formation

Additional plaques may develop over time.

Xanthelasma and Cardiovascular Health

While xanthelasma itself is harmless, studies have found associations between xanthelasma and cardiovascular risk factors in some individuals.


Cholesterol Assessment

Evaluation may identify previously unknown lipid abnormalities.

Risk Factor Management

Managing blood pressure, cholesterol, and diabetes supports overall health.

Preventive Care

Lifestyle changes may reduce long-term cardiovascular risk.

Prognosis

The prognosis of xanthelasma is excellent because it is a benign eyelid condition and does not become cancerous.


Vision

Xanthelasma typically does not affect vision.

Eye Function

Normal eyelid function is usually preserved.

Cosmetic Outcome

Removal procedures can improve appearance when desired.

Long-Term Outlook

Monitoring and metabolic management provide excellent outcomes.

Factors Affecting Outcome

Lesion Size

Larger plaques may require more extensive treatment.

Underlying Cholesterol Levels

Metabolic control influences recurrence risk.

Treatment Method

Different procedures have different cosmetic outcomes.

Skin Healing Response

Individual healing affects scarring and appearance.

Clinical Pearls

  • Xanthelasma is a benign cholesterol deposit disorder of the eyelids.
  • The classic appearance is a yellow, flat plaque near the medial eyelids.
  • Most cases are diagnosed clinically without biopsy.
  • Lipid evaluation should be considered because of possible systemic associations.
  • Not all yellow eyelid lesions are xanthelasma.
  • Rapid growth, pigmentation, ulceration, or unusual features require further evaluation.
  • Removal is usually cosmetic and does not prevent recurrence.
  • Healthy lifestyle choices support cardiovascular health.

Common ICD-10 Codes

Code Description
H02.6 Xanthoma of eyelid
E78.00 Pure hypercholesterolemia, unspecified
E78.2 Mixed hyperlipidemia
E78.5 Hyperlipidemia, unspecified
E11.9 Type 2 diabetes mellitus without complications

Patient Education: Living With Xanthelasma

Monitor Cholesterol

Regular lipid testing may help identify metabolic concerns.

Healthy Lifestyle

Balanced nutrition and exercise support overall health.

Protect Skin

Sun protection helps maintain eyelid skin health.

Seek Evaluation

New or changing eyelid lesions should be examined.

Frequently Asked Questions

What causes xanthelasma?

Xanthelasma occurs when cholesterol-containing cells accumulate within the eyelid skin.

Is xanthelasma dangerous?

No. Xanthelasma is benign and does not become eyelid cancer.

Does xanthelasma mean I have high cholesterol?

Not always, but lipid testing may be recommended because some patients have underlying cholesterol abnormalities.

Can xanthelasma disappear on its own?

Existing deposits usually do not disappear without treatment.

Can xanthelasma return after removal?

Yes. Recurrence can occur, especially when underlying lipid problems remain.

Related Eye Conditions

Eyelid Tumors

Growths of eyelid tissue that may resemble benign lesions.

Seborrheic Keratosis

Benign skin growth affecting the eyelid.

Chalazion

Blocked meibomian gland causing eyelid swelling.

Milia

Small keratin-filled eyelid cysts.

Sebaceous Carcinoma

Malignant meibomian gland tumor that may mimic benign lesions.

Hyperlipidemia

Systemic lipid disorder associated with cholesterol abnormalities.

Medical Disclaimer

The information provided by Kardia Vision is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.


Patients with new, changing, or uncertain eyelid lesions should seek evaluation from a qualified eye care professional.


Kardia Vision provides evidence-based eye health education for patients, students, and healthcare professionals.

Kardia Vision
Educational Eye Care Resource Center